课题基金 / 基金详情

MRI Probes for Mapping Retinal Activity In Vivo

MRI Probes for Mapping Retinal Activity In Vivo
用于绘制体内视网膜活动图的 MRI 探头
批准号:
6799949
负责人:
ANGELIQUE Y LOUIE
金额:
$14.85万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2006-08-31

项目摘要

项目成果

ANGELIQUE Y LOUIE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant?s Abstract) This proposal describes the development of probes for three-dimensional imaging of retinal activity. These probes are magnetic resonance imaging (MRI) contrast agents that are sensitive to membrane potentials. It is the signal from water protons that provides the image in typical MRI images and contrast agents interact with water to enhance that signal. In our previous work we have shown that by blocking the interaction of water with the contrast agent we can "turn off? enhancement, and then selectively "turn on" enhancement by removing the block. In these previous experiments we added a blocking group to the contrast agent that is removable by enzyme cleavage, so that signal enhancement was dependent upon enzyme cleavage. Based on these results we hypothesize that we can modulate the ability of an agent to enhance MRI signal by adding a group that is sensitive to membrane potentials, thus making signal enhancement dependent on membrane activity. In our research design we propose to: 1) Design and synthesize an agent based on a known optical indicator of membrane potentials 2) Characterize the ability of the new agent to enhance contrast in cell-free and cell culture systems. 3) Perform studies leading to the application of the new agents in eyes in vivo. These studies include determining the optimal route of delivery for the agent, and its biodistribution in model animal studies. These investigations will ultimately be extended to rodent models of retinal degeneration to map the loss of retinal activity over time and correlate the results with those observed by traditional methods. Results of the proposed studies will provide a noninvasive method to image membrane activity in deep tissues; this may aid in the early diagnosis of retinal disease. While our ultimate goal is to apply these agents in studies of macular degeneration, these agents would be useful for observations of any system in which membrane signaling activity plays a role.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/anie.200900984
发表时间: 2009
期刊: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子: 16.6
作者: [Tu, Chuqiao, Nagao, Ryan, Louie, Angelique Y.]
通讯作者: Louie, Angelique Y.
Trackable, Targeted Anticoagulants for Atrial Fibrillation
  • 批准号:
    9565788
  • 项目类别:
  • 资助金额:
    $56.37万
  • 财政年份:
    2017
  • 负责人:
    ANGELIQUE Y LOUIE
  • 依托单位:
Noninvasive imaging of eosinophils
  • 批准号:
    8444241
  • 项目类别:
  • 资助金额:
    $16.77万
  • 财政年份:
    2013
  • 负责人:
    ANGELIQUE Y LOUIE
  • 依托单位:
Noninvasive imaging of eosinophils
  • 批准号:
    8715682
  • 项目类别:
  • 资助金额:
    $21.54万
  • 财政年份:
    2013
  • 负责人:
    ANGELIQUE Y LOUIE
  • 依托单位:
UCD BME Translational Design and Innovation Program
  • 批准号:
    8249828
  • 项目类别:
  • 资助金额:
    $4.32万
  • 财政年份:
    2011
  • 负责人:
    ANGELIQUE Y LOUIE
  • 依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    周雄辉
  • 依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2011
  • 负责人:
    颜桥
  • 依托单位:
生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
  • 批准号:
    81101308
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2011
  • 负责人:
    李海霞
  • 依托单位:
精神分裂症记忆障碍的脑网络组学研究
  • 批准号:
    91132301
  • 项目类别:
    重大研究计划
  • 资助金额:
    350.0万元
  • 批准年份:
    2011
  • 负责人:
    蒋田仔
  • 依托单位: